TIBSETilaknagar Industries Ltd-$MediumNeutral
Announced Fri, 29 May · 21:08 IST

Please find enclosed herewith Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 2015 for the Audited Financial Results for the quarter and financial year ended March 31, 2026.

Mgmt Guided Margin ImprovementCfo Debt Reduction RoadmapInvestor Communications View source PDF

TI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.6%1-day move
₹457.00
prior close
₹456.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.6-3.6-4.9-5.9-6.6-7.7-9.0-8.9-6.6-5.4-3.6-0.9
Up moveDown movePending
AI summary

Tilaknagar Industries reported strong Q4 FY26 results with volumes of 8 million cases (up 135% YoY) and revenue of INR 949 crore (up 147.5% YoY). For FY26, total volumes reached 20 million cases with revenue of INR 2,346 crore, representing 68% growth. Mansion House Brandy achieved a record 10 million cases milestone, cementing its position as India's largest P&A brandy. EBITDA for FY26 stood at INR 419 crore with 17.9% margin. The company completed Imperial Blue acquisition in November 2025 and has 75% of IB volumes now under TI operations. Gross debt increased significantly to INR 2,295 crore (from INR 42 crore) primarily for IB acquisition financing. The Board has recommended a dividend of Rs. 1 per share for FY26.

Likely market impact

The strong operational performance driven by Imperial Blue integration and Mansion House growth signals solid execution. However, elevated debt levels (Net Debt of INR 1,911 crore) and margin pressure from input costs warrant monitoring. The company's 3-year guidance targets double-digit volume growth and 16-18% EBITDA margin by FY29, along with Net Debt/EBITDA below 1.0x.